Kinetic analysis of drug-protein interactions by affinity chromatography

Cong Bi, Sandya Beeram, Zhao Li, Xiwei Zheng, David S Hage

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Information on the kinetics of drug-protein interactions is of crucial importance in drug discovery and development. Several methods based on affinity chromatography have been developed in recent years to examine the association and dissociation rates of these processes. These techniques include band-broadening measurements, the peak decay method, peak fitting methods, the split-peak method, and free fraction analysis. This review will examine the general principles and applications of these approaches and discuss their use in the characterization, screening and analysis of drug-protein interactions in the body.

Original languageEnglish (US)
Pages (from-to)16-21
Number of pages6
JournalDrug Discovery Today: Technologies
Volume17
DOIs
StatePublished - Oct 1 2015

Fingerprint

Drug Interactions
Affinity Chromatography
Proteins
Drug Discovery

ASJC Scopus subject areas

  • Drug Discovery
  • Biotechnology
  • Molecular Medicine

Cite this

Kinetic analysis of drug-protein interactions by affinity chromatography. / Bi, Cong; Beeram, Sandya; Li, Zhao; Zheng, Xiwei; Hage, David S.

In: Drug Discovery Today: Technologies, Vol. 17, 01.10.2015, p. 16-21.

Research output: Contribution to journalArticle

Bi, Cong ; Beeram, Sandya ; Li, Zhao ; Zheng, Xiwei ; Hage, David S. / Kinetic analysis of drug-protein interactions by affinity chromatography. In: Drug Discovery Today: Technologies. 2015 ; Vol. 17. pp. 16-21.
@article{61183f686c1e48329f2830e50a48adbd,
title = "Kinetic analysis of drug-protein interactions by affinity chromatography",
abstract = "Information on the kinetics of drug-protein interactions is of crucial importance in drug discovery and development. Several methods based on affinity chromatography have been developed in recent years to examine the association and dissociation rates of these processes. These techniques include band-broadening measurements, the peak decay method, peak fitting methods, the split-peak method, and free fraction analysis. This review will examine the general principles and applications of these approaches and discuss their use in the characterization, screening and analysis of drug-protein interactions in the body.",
author = "Cong Bi and Sandya Beeram and Zhao Li and Xiwei Zheng and Hage, {David S}",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.ddtec.2015.09.003",
language = "English (US)",
volume = "17",
pages = "16--21",
journal = "Drug Discovery Today: Technologies",
issn = "1740-6749",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Kinetic analysis of drug-protein interactions by affinity chromatography

AU - Bi, Cong

AU - Beeram, Sandya

AU - Li, Zhao

AU - Zheng, Xiwei

AU - Hage, David S

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Information on the kinetics of drug-protein interactions is of crucial importance in drug discovery and development. Several methods based on affinity chromatography have been developed in recent years to examine the association and dissociation rates of these processes. These techniques include band-broadening measurements, the peak decay method, peak fitting methods, the split-peak method, and free fraction analysis. This review will examine the general principles and applications of these approaches and discuss their use in the characterization, screening and analysis of drug-protein interactions in the body.

AB - Information on the kinetics of drug-protein interactions is of crucial importance in drug discovery and development. Several methods based on affinity chromatography have been developed in recent years to examine the association and dissociation rates of these processes. These techniques include band-broadening measurements, the peak decay method, peak fitting methods, the split-peak method, and free fraction analysis. This review will examine the general principles and applications of these approaches and discuss their use in the characterization, screening and analysis of drug-protein interactions in the body.

UR - http://www.scopus.com/inward/record.url?scp=84951801371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951801371&partnerID=8YFLogxK

U2 - 10.1016/j.ddtec.2015.09.003

DO - 10.1016/j.ddtec.2015.09.003

M3 - Article

VL - 17

SP - 16

EP - 21

JO - Drug Discovery Today: Technologies

JF - Drug Discovery Today: Technologies

SN - 1740-6749

ER -